{
  "id": 17217755,
  "title": "Sanofi has no plans for a 'major' overhaul as Dupixent's patent cliff looms",
  "url": "https://urgent.news/2026/10/30/sanofi-has-no-plans-for-a-major-overhaul-as-dupixents-patent-cliff",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-30T11:12:36.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/sanofi-has-no-plans-for-a-major-overhaul-as-dupixents-patent-cliff-looms/"
  },
  "original_language": "en",
  "account": null,
  "summary": "It’s been six months since Belén Garijo took over as the CEO for Sanofi, and the French drugmaker said Friday it is not planning “major” changes to its business or R&D pipeline as the early ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}